INTRANASAL STIMULATION FOR TREATMENT OF MEIBOMIAN GLAND DISEASE AND BLEPHARITIS

    公开(公告)号:US20170312521A1

    公开(公告)日:2017-11-02

    申请号:US15584956

    申请日:2017-05-02

    Applicant: Oculeve, Inc.

    Abstract: Described here are devices, systems, and methods for treating meibomian gland disease and/or blepharitis by providing intranasal stimulation. Generally, the devices may deliver electrical stimulation to the nasal mucosa. Intranasal stimulation may unblock obstructed meibomian glands and increase the lipid content of tears, both acutely during stimulation and subsequent to intranasal stimulation. The methods may include an initial round of stimulation to unblock obstructed meibomian glands, and subsequent shorter rounds of stimulation to cause meibum secretion and maintain the open glands.

    CONTACT LENS FOR INCREASING TEAR PRODUCTION
    47.
    发明申请
    CONTACT LENS FOR INCREASING TEAR PRODUCTION 有权
    联系镜头增加生产力

    公开(公告)号:US20160114172A1

    公开(公告)日:2016-04-28

    申请号:US14920847

    申请日:2015-10-22

    Applicant: Oculeve, Inc.

    Abstract: Described here are devices, systems, and methods for increasing tear production by stimulating the cornea, conjunctiva, and/or subconjunctiva. In some variations, the devices may be in the form of a contact lens. The contact lens may comprise a lens body and a stimulator chip, where the stimulator chip is embedded in the lens body. An external power source wirelessly transmits energy to the stimulator chip, where the stimulator chip may convert the energy to an electric waveform to stimulate the cornea, conjunctiva, and/or subconjunctiva. Stimulation may activate the lacrimal reflex to increase tear production. The devices and systems for increasing tear production may be used in methods of treating dry eye, reducing the symptoms of tired eye, increasing comfort for contact lens wearers, and extending the number of years a contact lens user can wear contacts. Also described are methods of manufacturing a contact lens.

    Abstract translation: 这里描述了通过刺激角膜,结膜和/或结膜下增加泪液产生的装置,系统和方法。 在一些变型中,装置可以是隐形眼镜的形式。 隐形眼镜可以包括透镜体和刺激器芯片,其中刺激器芯片嵌入在透镜体中。 外部电源将能量无线地传输到刺激器芯片,其中刺激器芯片可以将能量转换成电波形以刺激角膜,结膜和/或结膜下。 刺激可以激活泪液反射以增加泪液产生。 用于增加泪液生产的装置和系统可以用于治疗干眼症,减少疲劳眼睛的症状,增加隐形眼镜佩戴者的舒适度以及延长隐形眼镜用户可佩戴接触的年数的方法。 还描述了制造隐形眼镜的方法。

    Devices and methods for treating dry eye in animals
    48.
    发明授权
    Devices and methods for treating dry eye in animals 有权
    用于治疗动物干眼症的装置和方法

    公开(公告)号:US09265956B2

    公开(公告)日:2016-02-23

    申请号:US14201753

    申请日:2014-03-07

    Applicant: Oculeve, Inc.

    CPC classification number: A61N1/37217 A61N1/0526 A61N1/36046

    Abstract: Described here are devices, systems, and methods for treating a condition in an animal. Generally the systems include a stimulator that is implantable in the animal and a controller system configured to transmit one or more signals to the implanted stimulator. The controller system may have a controller configured to generate the one or more signals. The controller system may include one or more collars, bridles, horse hoods, cages, animal beds, and/or food bowls. The systems may be used to treat one or more conditions such as dry eye, and may treat the conditions in an animal such as a horse, dog, or cat.

    Abstract translation: 这里描述了用于治疗动物状况的装置,系统和方法。 通常,系统包括可植入动物的刺激器和被配置为将一个或多个信号传输到植入的刺激器的控制器系统。 控制器系统可以具有被配置为产生一个或多个信号的控制器。 控制器系统可以包括一个或多个衣领,绷腿,马罩,笼子,动物床和/或食物碗。 该系统可用于治疗一种或多种病症如干眼症,并且可以治疗动物如马,狗或猫的病症。

    STIMULATION DEVICES AND METHODS FOR TREATING DRY EYE

    公开(公告)号:US20210031040A1

    公开(公告)日:2021-02-04

    申请号:US16995520

    申请日:2020-08-17

    Applicant: Oculeve, Inc.

    Abstract: Described herein are devices and methods of use thereof for treating dry eye, tired eye, or other forms of ocular discomfort such as from contact lenses. The methods generally include applying spatially and/or temporally patterned stimulation to one or more anatomical structures located in an ocular or nasal region. The electrical stimulation may elicit a reflex that activates the lacrimal gland or may directly activate the lacrimal gland or nerves innervating the lacrimal gland to produce tears. The devices may be implantable or handheld, and may be configured to deliver the spatially and/or temporally patterned stimulation patterns described.

    Stimulation devices and methods for treating dry eye

    公开(公告)号:US10780273B2

    公开(公告)日:2020-09-22

    申请号:US16137464

    申请日:2018-09-20

    Applicant: Oculeve, Inc.

    Abstract: Described herein are devices and methods of use thereof for treating dry eye, tired eye, or other forms of ocular discomfort such as from contact lenses. The methods generally include applying spatially and/or temporally patterned stimulation to one or more anatomical structures located in an ocular or nasal region. The electrical stimulation may elicit a reflex that activates the lacrimal gland or may directly activate the lacrimal gland or nerves innervating the lacrimal gland to produce tears. The devices may be implantable or handheld, and may be configured to deliver the spatially and/or temporally patterned stimulation patterns described.

Patent Agency Ranking